ArticleRheumatology international2026
Dermatomyositis predominates among checkpoint inhibitor-associated inflammatory myositis phenotypes: a pharmacovigilance disproportionality analysis identifies a class-wide signal.
Connor FreyPubMed ↗Publisher ↗
No numbers read from the abstract.